Table 3 Conclusions of Japanese studies compared with those of international HTA reports
Diseases | Number of studies | Mean quality score | Comparative study (%) | Positive conclusion* (%) | International HTA report | Recommendation of PET use in oncology |
|---|---|---|---|---|---|---|
Lung cancer | 30 | 7.2 | 11 (37) | 8 (27) | â—‹ (SNP, NCLC) | Yes (SNP, NCLC) |
Lymphoma | 5 | 6 | 4 (80) | 3 (60) | Ă— | No |
Head and neck cancer | 12 | 6.7 | 5 (42) | 5 (42) | â—‹ | Yes |
Colorectal cancer | 8 | 6.6 | 3 (38) | 4 (50) | Ă— | No |
Breast cancer | 10 | 5.7 | 4 (40) | 3 (30) | Ă— | No |
Esophageal cancer | 4 | 8.8 | 3 (75) | 1 (25) | Lack of evidence | No |
Stomach cancer | 4 | 5.8 | 2 (50) | 3 (75) | Lack of evidence | - |
Pancreatic cancer | 6 | 8.7 | 4 (67) | 4 (67) | Unclear | Yes |
Cervical cancer | 4 | 7.5 | 3 (75) | 3 (75) | Lack of evidence | - |
Ovarian cancer | 4 | 6.3 | 4 (100) | 3 (75) | â—‹ | - |
Uterine cancer | 6 | 7.8 | 3 (50) | 0 (0) | Lack of evidence | - |